Oct-2026
Sales
Trend
6-Month
Product Count
SKUs
Avg Price
YoY Sales Change
YoY Price Change
Is this your brand?
See your full sales and distribution data: where you sell, how you're priced, and how you rank against the brands next to you on the shelf.
See your brand's dataCarry this brand in your store?
Headset Retailer is free. Connect your POS and see what's selling and what's sitting.
Sign up freeMarket Insights Snapshot
In October 2026, Dosecann’s mix concentrated in Capsules at 50.25% share with year-over-year decline of 31.57% and month-over-month growth of 21.24%, while Vapor Pens rose to 40.30% share with year-over-year growth of 38.92% and month-over-month growth of 41.72%. Smaller lines contracted: Topical held 5.63% share with a 78.26% year-over-year drop and Oil fell to 3.82% share with a 93.98% year-over-year decline and an 85.27% month-over-month slide. With brand sales down 48.29% year over year and average price up 8.84%, the pattern implies a pivot toward higher-velocity inhalables driving near-term volume offset while legacy wellness formats compress.
The acceleration in Vapor Pens alongside a stabilizing Capsules base indicates a repositioning from traditional wellness to inhalation-led occasions, with a 41.72% month-over-month surge in Vapor Pens and a concurrent 21.24% month-over-month lift in Capsules supporting mix rebalancing. However, a Vapor Pens category rank of 91 in Ontario and a 93.98% year-over-year collapse in Oil suggest limited breadth across form factors despite October 2026 gains, implying Dosecann must consolidate share in two categories rather than pursue a broad portfolio.
Competitive Landscape
Dosecann sits at rank #91 in ON Vapor Pens in October 2026, improving 8 positions from #99 year over year but slipping 3 spots from #88 at its January 2026 peak; over the last three months the brand moved from #98 to #91, a 7-rank climb that contrasts with category leaders where Back Forty / Back 40 Cannabis held #1 with 47.9% YoY sales growth and Spinach advanced from #3 to #2 with 135.5% YoY growth. Compared with BoxHot sliding from #2 to #3 despite 30.8% YoY growth and Kolab leaping from #14 to #5 on 118.8% YoY growth, Dosecann’s modest rank gain of 8 positions alongside a 3-position dip from its peak indicates incremental recovery rather than breakout momentum, implying the brand is stabilizing in the lower tier unless it accelerates share capture beyond single-digit rank shifts.
Notable Products
Dosecann’s October 2026 sales are concentrated in Capsules and Cartridges, with CBD 50 Capsules 30-Pack (1500mg CBD) alone at 50.2% and Cartridges contributing 36.0%. With no new products accounting for 0.0% of sales, most of its sales ride on evergreen items, so most of its sales ride on a few established formats.
Peer avg: average price of the same product type and package size in the same states that month.
Top Selling Cannabis Brands
Data for this report comes from real-time sales reporting by participating cannabis retailers via their point-of-sale systems, which are linked up with Headset’s business intelligence software. Headset’s data is very reliable, as it comes digitally direct from our partner retailers. However, the potential does exist for misreporting in the instance of duplicates, incorrectly classified products, inaccurate entry of products into point-of-sale systems, or even simple human error at the point of purchase. Thus, there is a slight margin of error to consider. Brands listed on this page are ranked in the top twenty within the market and product category by total retail sales volume.






